Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 12:15:143-186.
doi: 10.2147/PROM.S438290. eCollection 2024.

Engaging Stakeholders to Develop a Roadmap for Dry Eye and MGD PCORI-Funded Research

Natalia A Warren #  1   2 , Steven L Maskin #  3 , Varadraj Gurupur #  4 , Deidre A Rector #  1 , Diana Adelman #  1 , Susan Howell #  1 , John McAree #  1 , Ruthie Dibble #  1 , Celia Carlisano #  1 , David P Maconi #  1 , Dirk Schrotenboer #  5 , Maria Jaimes #  3 , Nancy Marte #  3 , Theresa Carlisano #  1 , Claire Toland #  3 , Jongik Chung #  6 , Sandra L Cremers  7 , Glenn S Corbin  8
Affiliations

Engaging Stakeholders to Develop a Roadmap for Dry Eye and MGD PCORI-Funded Research

Natalia A Warren et al. Patient Relat Outcome Meas. .

Abstract

Introduction: Although affecting an estimated 35% of the population, Dry Eye is not well understood by patients and the medical community. As a result, both in research and clinical settings, diagnostic and treatment protocols tend to be non-specific, ad hoc, and inadequate, with a narrow industry-driven focus. The purpose of this convening was to propose a research roadmap that orients Dry Eye researchers toward a comprehensive patient-centered approach to diagnosing and treating Dry Eye, Meibomian gland dysfunction (MGD), and related comorbidities with a goal of improving clinical outcomes for Dry Eye/MGD patients.

Methods: Sixteen participants, including Dry Eye/MGD patients, caregivers, and patient advocates together with a group of experts in Dry Eye, MGD and other fields identified gaps in research on Dry Eye and MGD diagnostic and treatment approaches (age range 20-80; male to female ratio of 7:11; patients: 7). During a 2-day virtual convening, participants were assigned to topic-specific focus-group sessions to discuss and develop research questions pertaining to Dry Eye and MGD. The research questions were compiled into a proposed patient-centered roadmap for Dry Eye and MGD research. Two additional participants contributed to the proposed roadmap following the convening.

Results: The focus groups identified over 80 patient-centered research questions important to patients and other stakeholders and compiled these into a proposed research roadmap.

Conclusion: The convened stakeholders aim to establish a cohesive and comprehensive patient-centered approach to treating Dry Eye, Meibomian Gland Dysfunction, and comorbidities. The research roadmap will serve as a reference for researchers, educational institutions, clinicians, and others evaluating diagnostic and treatment protocols in Dry Eye and MGD.

Keywords: Meibomian gland dysfunction; dry eye disease; ocular surface disease; patient advocacy; patient care; patient-centered research.

PubMed Disclaimer

Conflict of interest statement

All authors received honoraria from PCORI for their participation in this work. Natalia A. Warren, Diana Adelman, Deidre A. Rector, and Claire Toland reported receiving additional financial support for their extended contributions. Dr. Steven L. Maskin reported owning >5% of MGDinnovations, Inc, a corporation receiving patent-based royalties (patent numbers: 9510844, 10159599, and 11110003) from a licensing agreement with Katena Products. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Phases and Project Flow. The phases of the project (white rectangles) and primary activity (grey rectangles).
See this image and copyright information in PMC

References

    1. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472–478. doi:10.1097/ICO.0b013e318225415a - DOI - PubMed
    1. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocular Surf. 2017;15(3):334–365. - PubMed
    1. Maskin SL, Warren NA. Your Dry Eye Mystery Solved: Reversing Meibomian Gland Dysfunction, Restoring Hope. Yale University Press; 2022.
    1. Saldanha IJ, Le JT, Solomon SD, et al. Choosing Core outcomes for use in clinical trials in ophthalmology: perspectives from three ophthalmology outcomes working groups. Ophthalmology. 2019;126(1):6–9. doi:10.1016/j.ophtha.2018.09.008 - DOI - PMC - PubMed
    1. Saldanha IJ, Petris R, Han G, Dickersin K, Akpek EK. Research questions and outcomes prioritized by patients with dry eye. JAMA Ophthalmol. 2018;136(10):1170–1179. doi:10.1001/jamaophthalmol.2018.3352 - DOI - PMC - PubMed